GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.

CONCLUSION: Our results reveal that GTSE1 played a key role in the progression of breast cancer, indicating that GTSE1 could serve as a novel biomarker to aid in the assessment of the prognosis of breast cancer.
PMID: 30961661 [PubMed - in process]

Source: Clinical Breast Cancer - April 7, 2019 Category: Cancer & Oncology Authors: Lin F, Xie YJ, Zhang XK, Huang TJ, Xu HF, Mei Y, Liang H, Hu H, Lin ST, Luo FF, Lang YH, Peng LX, Qian CN, Huang BJ Tags: J Exp Clin Cancer Res Source Type: research